Drug factory · FDA FEI 3011194531

Spark Therapeutics, Inc.

3737 Market Street, Suite 1300, Philadelphia, PA, United States

United States: 1

No FDA drug inspection on record.

FDA's public inspection data (fiscal year 2009 on) has no drug inspection for this plant. That doesn't mean anything is wrong: FDA picks plants by risk, and some are inspected rarely or not yet.

What it does, for whom

DrugRoleForNDC
Voretigene NeparvovecMakes the active ingredient and tests it Spark Therapeutics, Inc. 71394-415

Registered with FDA for: analysis; api manufacture.